Developing and commercializing peptide therapeutics for nerve regeneration: an interview with NervGen Pharma
Learn more about NervGen Pharma (BC, USA), a company developing innovative peptide-based therapeutics to treat spinal cord injuries. In this interview, we spoke to Jerry Silver, co-inventor and Scientific Advisor, Ernest Wong, President and CEO, and Bill Radvak, co-founder and Executive Chairman, NervGen Pharma (BC, USA) to learn more about their history, technology and journey to commercialization. Please introduce yourself and your institution. Jerry Silver (JS): I received my PhD from Case Western Reserve in 1974 and did post-doctoral work at Harvard University in the Department of Neurosciences at The Children’s Hospital and in the Neuropathology Department at Harvard Medical...